Our study has confirmed that DHT can increase the secretion of CD9 positive EV and DHT alters EV content and that CD9 positive EV measurement in patients’ blood based-biofluids may provide alternative biomarkers for prostate cancer patients. Here, CD9 is linked to Familial prostate cancer.